Clinical Trial Update: Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lomitapide in Japanese patients with homozygous familial hypercholesterolemia on concurrent lipid-lowering therapy has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia Homozygous

Drugs mentioned

• Lomitapide (lomitapide)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Familial Hypercholesterolemia - Homozygous | Phase 3 | Status: COMPLETED | Results posted: 2018-10-10